Skip to main content
Latest news
Browse specialties
Breast cancer Genitourinary cancers Lung & thoracic cancers
In focus
Next-generation sequencing: Emerging biomarkers in thyroid and NSCLCs ctDNA and bladder cancer: Current understanding and beyond ROS1 fusion-positive NSCLC NSCLC driver mutations: Discussing the importance of RET, ALK and ROS1 alterations in NSCLC Early-stage NSCLC management: Surgery, targeted treatment and immunotherapy ALK fusion-positive NSCLC: International approaches to management RET fusion-positive NSCLC: Informing on the use of pralsetinib for patients with RET fusion-positive, advanced NSCLC COVID-19 & cancer
Conferences
SABCS 2022 ESMO 2022 2022 ASCO Annual Meeting
About us
Medicine Matters Oncology
EXTENDED SEARCH

Medicine Matters oncology

Turin, Italy

Professor Novello graduated in Medicine from The University of Turin, Italy in 1995. She then did a Postgraduate Course in Respiratory Medicine. In 2006 she achieved a PhD in Human Oncology and went on to do a Postgraduate in Medical Oncology.

In the past she has worked at S. Luigi Hospital, Clinic of Respiratory Diseases, Turin; the Institut Gustave Roussy, Villejuif, France and Thoracic Oncology Division, University of Turin. Now, she is Assistant Professor of Respiratory Medicine at The University of Turin, Department of Clinical and Biological Sciences, where her main area of research is based on the aspects of basic research and applied clinical research concerning bronchogenic carcinoma.

She has been involved in trials and studies in different lung cancer and pleural mesothelioma clinical stages including among others: supportive care, the treatment of lung cancer in elderly patients, the role of cytokines in thoracic malignancies (lung cancer, pleural mesothelioma), the role of oncogenes, antioncogenes, growth factors and their receptors in lung cancer (pathogenesis, prognosis), women and lung cancer, pharmacogenomics and lung cancer and applied clinical research aspects regarding interstitial lung disease.

Professor Novello is a Member of the American Society of Clinical Oncology (ASCO), Member of “Innovators in Lung Cancer”, Member of IASLC and Board of Director Member since July 2011, Member of NLCP (National Lung Cancer Partnership) Scientific Committee, Member of IASLC Young Investigators Awards Scientific Committee, BOD IASLC from 2011 until 2015 and President of the European Association – Women Against Lung Cancer in Europe (WALCE).